BioSpace News Archive

Nascent Biotech, Inc., (OTCQB: NBIO), a biotechnology company developing proprietary human Monoclonal Antibodies (mAbs) and immunotherapy for treatment of cancer, today announced that it will be presenting at the Planet MicroCap Showcase 2020 on Wednesday, April 22 at 7:00 AM EST.

Envisagenics, a company developing therapeutics for RNA splicing errors that often lead to genetic disorders including cancer, announced today that it has entered into a research program agreement with the Lung Cancer Initiative (LCI) at Johnson & Johnson.

Shinkowa Pharmaceutical Co., Ltd. (Head Office: Tokyo Chuo-Ward, CEO: Megumi Tanaka) is the largest nutraceutical (health supplemental food which is scientifically proved) producer of β-nicotinamide mononucleotide (NMN) blended nutraceutical, which is effective to maintain health and longevity, providing high-purity NMN to universities and researchers both domestic and foreign.

Colorado BioScience Association (CBSA) today welcomed new officers and members to its board of directors, including new board chair, Bob Reddy, and new board vice chair, Dr. Kathleen (Kiki) Traylor.

In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits for serology-based antibody detection by ELISA of patients who have been exposed to COVID-19

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, has extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies that are specific for ipilimumab (Yervoy) and the ipilimumab/CTLA-4 drug-target complex

Regenstrief Institute and partners have developed a data dashboard to support COVID-19 tracking and response in the state of Indiana

Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) announced today that the Company has entered into a research collaboration with the Fraunhofer Institute for Cell Therapy and Immunology (IZI) and acquired related patents from the Institute for a meprin protease inhibitor and assay platform.

Medications for lupus — a long-term autoimmune disease that occurs when a person’s immune system attacks different parts of their body, including their skin — are currently being explored as a treatment for COVID-19 patients.

BioSig Technologies, Inc. appointed Mr. Anthony Zook to the Board of Directors of its majority-owned subsidiary ViralClear Pharmaceuticals, Inc.